栓塞预防设备市场规模、份额、成长分析，按类型、按材料、按适应症、按应用、按地区 - 行业预测，2024-2031 年

2022年全球栓塞防护装置市场规模将为5.5455亿美元，从2023年的6.0488亿美元增长到2031年的11.4641亿美元，并预计在预测期内持续增长（2024年-预计将以复合年增长率增长） 2031 年将成长 8.32%）。

全球栓塞防护设备市场是医疗设备业中快速成长的一个领域，在这种情况下，血栓和血液碎片可能会脱落并穿过血液，导致重要器官阻塞。这些设备在各种侵入性心血管手术中捕捉这些栓子，包括置换术主动脉瓣置换术 (TAVR)、颈动脉支架置入术和经皮冠状动脉介入治疗 (PCI)。该市场的驱动因素包括心血管疾病盛行率的增加、老年人口的增加以及微创手术的日益普及。栓塞防护装置的技术进步，例如新型过滤器设计、生物可吸收过滤器和远端闭塞系统的开发，正在进一步推动市场成长。此外，医疗保健专业人员对栓塞防护装置的好处和减少手术併发症的认识不断提高，导致其采用率不断提高。市场竞争非常激烈，有几家主要企业参与开发和行销这些设备。从地区来看，北美地区所占份额最大，其次是欧洲、亚太地区和其他地区。在技​​术进步、医疗保健支出增加以及新兴国家对微创手术需求不断增长的推动下，全球栓塞防护设备市场预计将继续呈上升趋势。

由于对先进医疗技术的需求不断增长和心血管疾病盛行率上升，预计美国栓塞防护设备市场将在预测期内稳定成长。随着医疗保健提供者和机构在介入心臟病学等手术过程中继续优先考虑患者安全，栓塞防护设备的整合变得至关重要。老年人口的成长和微创手术的普及进一步推动了市场的扩张。此外，设备设计和功能的技术进步以及创新产品的监管核准预计将增强市场活力。总之，这些因素显示美国栓塞防护设备市场前景光明，永续年增长率预计将吸引投资和研究倡议，最终改善心血管手术的患者预后。随着产业格局的发展，医疗保健相关人员必须继续关注这些趋势，以便利用医疗设备业。

目录

介绍

• 研究目的
• 定义
• 市场范围

调查方法

• 资讯采购
• 次要/一级资讯来源
• 市场规模预测
• 市场假设与限制

执行摘要

• 市场概况展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场动态
  • 促进因素
  • 机会
  • 抑制因素
  • 任务
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 监管环境
• 技术分析
• 专利分析
• 价值链分析

栓塞预防设备市场：依类型

• 市场概况
• 远端过滤装置
• 远端阻塞设备
• 近端阻塞设备

栓塞预防设备市场：依材料分类

• 市场概况
• 镍钛诺
• 聚氨酯

栓塞预防设备市场：依适应症分类

• 市场概况
• 经皮冠状动脉介入治疗
• 颈动脉疾病
• 大隐静脉移植疾病
• 经导管主动脉瓣置换术
• 其他适应症

栓塞预防设备市场：依应用分类

• 市场概况
• 心血管疾病
• 神经血管疾病
• 周围血管疾病

栓塞预防设备市场：依最终使用者分类

• 市场概况
• 医院
• 门诊手术中心

按地区分類的栓塞预防设备市场规模

• 市场概况
• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲 (MEA)
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲地区

竞争格局

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市集活动
• 主要企业市场占有率（2023年）

主要企业简介

• Medtronic
• Abbott Laboratories
• Boston Scientific
• Contego Medical
• Silk Road Medical
• Claret Medical
• Allium Medical Solutions
• Edwards Lifesciences
• Healthcare Solutions Holding, LLC
• Innovative Cardiovascular Solutions, LLC
• Transverse Medical, Inc.
• Keystone Heart Ltd.
• InspireMD, Inc.
• AngioDynamics, Inc.
• Emboline, Inc.
• Acandis GmbH & Co. KG
• Veryan Medical Ltd.
• Shanghai MicroPort Medical Co., Ltd.
• MedNova, Inc.

Global Embolic Protection Devices Market size was valued at USD 554.55 million in 2022 and is poised to grow from USD 604.88 million in 2023 to USD 1146.41 million by 2031, growing at a CAGR of 8.32% during the forecast period (2024-2031).

The Global Embolic Protection Devices Market is a rapidly growing sector in the medical device industry that focuses on preventing embolization, a condition where blood clots or debris dislodge and travel through the bloodstream, potentially causing blockages in vital organs. These devices are designed to capture and remove these emboli during various invasive cardiovascular procedures, such as transcatheter aortic valve replacement (TAVR), carotid artery stenting, and percutaneous coronary intervention (PCI). The market is being driven by factors such as the increasing prevalence of cardiovascular diseases, rising geriatric population, and the growing adoption of minimally invasive procedures. Technological advancements in embolic protection devices, such as the development of novel filter designs, bioresorbable filters, and distal occlusion systems, are further propelling market growth. Additionally, the rising awareness among healthcare professionals regarding the benefits of embolic protection devices and the need for reducing procedural complications has led to increased adoption. The market is highly competitive, with several key players involved in the development and distribution of these devices. Geographically, North America currently holds a significant share in the market, followed by Europe, Asia Pacific, and the rest of the world. The Global Embolic Protection Devices Market is expected to continue its upward trajectory in the coming years, driven by technological advancements, increasing healthcare expenditure, and a rising demand for minimally invasive procedures in emerging economies.

The US Embolic Protection Devices Market is expected to experience stable growth over the upcoming forecast period, driven by increasing demand for advanced medical technologies and rising prevalence of cardiovascular diseases. As healthcare providers and facilities continue to prioritize patient safety during procedures such as cardiovascular interventions, the integration of embolic protection devices is becoming essential. The growing geriatric population, coupled with a surge in minimally invasive surgeries, is further fueling market expansion. Additionally, technological advancements in device design and function, as well as regulatory approvals for innovative products, are expected to enhance market dynamics. These factors collectively signal a promising trajectory for the US Embolic Protection Devices Market, indicating a sustainable compound annual growth rate (CAGR) that will attract investment and research initiatives, ultimately improving patient outcomes in cardiovascular procedures. As the landscape evolves, stakeholders in the healthcare sector must remain attuned to these trends to leverage opportunities for growth and innovation in this critical segment of the medical device industry.

Top-down and bottom-up approaches were used to estimate and validate the size of the The Global Embolic Protection Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

The Global Embolic Protection Devices Market Segmental Analysis

Global Embolic Protection Devices Market is segmented by Type, Material, Indication, Application, End User, and Region. Based on Type, the market is segmented into Distal Filter Devices, Distal Occlusion Devices, Proximal Occlusion Devices. Based on Material, the market is segmented into Nitinol, Polyurethane. Based on Indication, the market is segmented into Percutaneous Coronary Intervention, Carotid Artery Diseases, Saphenous Vein Graft Disease, Transcatheter Aortic Valve Replacement, Other Indications. Based on Application, the market is segmented into Cardiovascular Diseases, Neurovascular Diseases, Peripheral Vascular Diseases. Based on End User, the market is segmented into Hospitals, Ambulatory Surgical Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the The Global Embolic Protection Devices Market

The increasing prevalence of cardiovascular diseases is a significant market driver for the Global Embolic Protection Devices Market. As conditions like coronary artery disease, peripheral artery disease, and valvular heart disease become more common globally, the demand for advanced embolic protection devices intensifies. These devices are essential in mitigating complications during invasive cardiovascular interventions, such as stent placements and angioplasty, thereby enhancing overall patient safety and outcomes. Moreover, the growing awareness of the benefits of employing these protective devices in clinical settings further propels their adoption, ultimately fueling market growth as healthcare providers aim to improve procedural success rates and reduce associated risks.

Restraints in the The Global Embolic Protection Devices Market

A significant market restraint for the Global Embolic Protection Devices market is the high cost of these technologies, which can impede their adoption, especially in emerging economies with constrained healthcare budgets. The substantial financial investment required for these devices, coupled with the need for specialized training and expertise for their effective application, creates barriers to entry and limits accessibility in certain regions. Consequently, this financial hurdle may inhibit widespread utilization and growth of the market. To counteract this issue, initiatives aimed at enhancing cost-effectiveness, alongside improved reimbursement frameworks, are essential for promoting broader acceptance and integration of embolic protection devices.

Market Trends of the The Global Embolic Protection Devices Market

The Global Embolic Protection Devices market is witnessing a significant trend driven by the increasing adoption of minimally invasive procedures across various medical specialties. Techniques such as transcatheter aortic valve replacement (TAVR), carotid artery stenting, and percutaneous coronary intervention (PCI) are becoming preferred options due to their benefits, including shorter hospital stays, quicker recovery times, and reduced complication rates when compared to traditional surgical methods. Consequently, there is a heightened demand for advanced embolic protection devices that effectively minimize the risk of emboli during these procedures. This trend is propelling innovation, with manufacturers focusing on developing specialized devices tailored for minimally invasive interventions, aligning with the changing preferences of healthcare providers and patients.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factor
• Degree of Competition
• Top Investment Pockets
• Ecosystem of the Market
• Regulatory Landscape
• Technology Analysis
• Patent Analysis
• Value Chain Analysis

Embolic Protection Devices Market, By Type

• Market Overview
• Distal Filter Devices
• Distal Occlusion Devices
• Proximal Occlusion Devices

Embolic Protection Devices Market, By Material

• Market Overview
• Nitinol
• Polyurethane

Embolic Protection Devices Market, By Indication

• Market Overview
• Percutaneous Coronary Intervention
• Carotid Artery Diseases
• Saphenous Vein Graft Disease
• Transcather Aortic Valve Replacement
• Other Indications

Embolic Protection Devices Market, By Application

• Market Overview
• Cardiovascular Diseases
• Neurovascular Diseases
• Peripheral Vascular Diseases

Embolic Protection Devices Market, By End User

• Market Overview
• Hospitals
• Ambulatory Surgical Centers

Embolic Protection Devices Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Medtronic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Contego Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Silk Road Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Claret Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allium Medical Solutions
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Edwards Lifesciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Healthcare Solutions Holding, LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Innovative Cardiovascular Solutions, LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Transverse Medical, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Keystone Heart Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• InspireMD, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Emboline, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Acandis GmbH & Co. KG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Veryan Medical Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shanghai MicroPort Medical Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MedNova, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments